https://www.linkedin.com/pulse/explaining-patients-declining-trust-doctors-robert-pearl-m-d–u3krc

For more than half a century, physicians ranked among the most trusted professionals in America. Even before modern medicine, when treatments usually failed, patients admired their doctors’ knowledge, dedication and compassion. Today, that trust has eroded, with profound implications for the future of U.S. healthcare.

Gallup polling shows just 44% of Americans rate the quality of care they receive as “good” or “excellent,” the weakest showing since Gallup began asking the question in 2001. Meanwhile, trust in doctors’ honesty and ethics has dropped 14 points since 2021, falling to its lowest point this century.

At first glance, you might assume that this decline resulted from recent developments: COVID-19, political polarization and rising vaccine skepticism. Instead, today’s drop in confidence is the predictable result of decisions set in motion some 20 years ago.

How the arc bent

To understand why patients now rate their doctors so poorly, we need to trace the full arc of modern medicine: how trust was built, how it peaked and why it declined.

The arc began with the arrival of antibiotics in the 1920s and ‘30s. Before then, doctors more often offered patients hope and compassion rather than cures. But with the availability of sulfa drugs and, later, penicillin, a doctor’s visit was more likely to prolong a life than shorten it.

The second half of the 20th century became medicine’s golden era. In this next section of the arc, breakthroughs in surgery, transplantation, chemotherapy and vaccines were paired with broader access through employer-sponsored insurance and the creation of Medicare and Medicaid. Life expectancy climbed year after year, and public confidence in doctors soared.

But every arc bends. By the 1990s, the daily demands of clinical practice had shifted. Acute problems like pneumonia or broken bones — conditions that often could be treated in a single encounter — gave way to chronic illnesses such as diabetes, heart failure and hypertension. These conditions demand lifelong management: frequent monitoring, medication adjustments and repeated follow-ups.

As chronic disease became more common, and as patients and patients struggled to manage these ever-present conditions, the result was an epidemic of heart attacks, strokes, cancers and kidney failures. Costs soared while clinical outcomes stagnated.

Insurers, caught between surging costs and payer resistance, had only one lever to pull: rationing. They rolled out high-deductible plans, imposed prior authorization requirements and denied more claims. Doctors, meanwhile, reassured by high patient satisfaction scores, resisted transformation. Most kept practicing in small, siloed offices under fee-for-service, a payment model that rewards volume over outcomes. Many who sought stability and greater reimbursement sold their practices to hospitals or private equity firms. Few found the relief they hoped for.

Why patients feel differently now, why doctors denied it

As the gap between patient needs and physician capacity widened, access to care steadily eroded. Appointments that once took days to schedule began stretching into weeks or even months, both in primary and specialty care. And when patients finally got through the door, visits felt hurried. With doctors averaging just 17 minutes per encounter, there was little time to listen fully, explain thoroughly or follow up afterward.

The consequences were predictable. Delayed appointments allowed medical problems to worsen. Rushed exams led to misdiagnoses. And for patients left waiting, worrying or returning with complications, the logical conclusion was that their doctors didn’t care.

Even as patients noticed the increasingly compromised quality, most medical professionals clung to the belief that small fixes could repair the system and restore the doctor-patient bond. They lobbied for a few more dollars from Medicare, a little less billing paperwork and fewer insurer-imposed prior authorizations. But with less than half of Americans now confident in the quality of care they receive — and premiums projected to rise nearly 9% next year — physicians can see that major healthcare reform is required. The era of denial is ending.

Patient confidence has now collapsed. A minority of Americans rate their care as excellent, and the data back them up. Life expectancy remains the same in the United States today as it was in 2010. And healthcare now consumes nearly one-fifth of the nation’s GDP, with half of Americans struggling to afford their medical bills. The question clinicians are asking is what can we do? Other industries provide answers.

Lessons from business turnarounds

Clay Christensen observed that companies and their leaders resist transformation until it is too late, and disaster strikes. Intel’s recent struggles illustrate how even once-great companies can go from the world’s best to an “also ran.” The lesson for the medical profession: that recognize the crisis early enough and embrace bold strategies are the ones that survive.

Their approach and ultimate success fall into two categories:

1. They maximize operational excellence to close the gap between demand and capacity. In the 1970s, for example, Southwest couldn’t match the major carriers on brand reputation, so it had to become cost effective. It chose to maximize collaboration. Pilots, flight attendants and ground crews operated as a tightly integrated team, following consistent steps at every airport. Planes turned around in 10 minutes, not 30. That efficiency allowed Southwest to schedule six flights a day (one more than the competition) without purchasing more planes or adding staff.
2. They embrace new technologies that can increase quality and lower cost. Take Netflix as an example. What began as a DVD-by-mail service pivoted early to streaming. Even before broadband was widespread, Netflix bet on the future. The model slashed costs, improved accessibility and delivered higher-quality viewing. Subscriptions stayed affordable, households remained loyal, and the company reshaped an entire industry.

Healthcare can learn from this. In this scenario, doctors would join together to achieve economies of scale, collaborate across specialties to avoid duplication of services and minimize resource waste through clinical care coordination. Moreover, they would apply the principle of specialization to create high-volume centers of excellence capable of providing consistently high quality with far greater efficiency and significantly lower costs.

Medicine could emulate this approach. Physicians would embrace generative AI, take financial risk under a capitated model, find ways to better control chronic disease and empower patients to take on more of their own care. This would decrease demand on doctors, free-up time for their most complex patients and reduce burnout. But this scenario won’t happen if the payment methodology remains “pay-for-volume,” or if new technologies are relegated to administrative tasks rather than applied to improve clinical effectiveness and efficiency.

Of course, there is a third possibility: doctors cling to denial. In this scenario, they keep running faster and faster on the treadmill, cutting more corners each year and hoping small fixes will make a difference.

If this is the path medicine follows, annual costs will outpace inflation, quality will continue to decline, and the gap between healthcare prices and what patients can afford will widen. To fill in the void, entrepreneurs will seize the opportunity and develop generative AI tools that replace (rather than complement) physicians. When that day comes, doctors will regret not acting while they still could.

https://www.linkedin.com/pulse/tim-cooks-legacy-offers-doctors-lesson-money-mission-pearl-m-d–qm8sc

In a 2015 commencement address at George Washington University, Apple CEO Tim Cook told graduates that their values should serve as their “North Star.” Work, he said, takes on new meaning when people feel pointed in the right direction. Otherwise, “it’s just a job, and life is too short for that.”

For generations, American medicine was built on a similar idea: that being a doctor was not just a job, but a calling rooted in service.

Doesn’t seem so long ago that most physicians practiced in small, independent offices, deciding for themselves which patients to see, how long to spend with each and how care would be delivered. Their identity and purpose were clear. They were doctors, trained through years of sacrifice to keep people healthy, relieve suffering and save lives.

That era of medicine has been replaced by one in which physicians increasingly struggle to balance mission and financial stability. In that tradeoff, most have chosen stability.

All but 38% of physicians have left or sold their practices. The majority now work for hospital systems, private equity firms or insurers in return for greater negotiating clout, administrative support and economic security. Among those who remain independent, a growing number have embraced concierge medicine, a model in which patients pay an annual fee (typically several thousand dollars, with some practices charging $20,000 or more) for enhanced access and personalized care. For physicians, the appeal is clear: fewer patients, more time per visit and higher income.

These choices are rational. For most doctors, they feel like the only way to protect their families, preserve their careers and survive inside an increasingly unforgiving system.

CFOs often say there can be no mission without margin. They are right. Financial stability matters in medicine, as it does in every profession. But the reverse is also true: without mission, medicine risks becoming, in Tim Cook’s words, “just a job.”

That is the danger many physicians may not fully recognize when they trade independence, access or autonomy for financial security. The gain is visible immediately. The loss only becomes clear only over time.

Cook’s recent retirement, and the debate over his legacy, offers a powerful case study in what happens when institutional optimization and personal values collide. His story helps illuminate the choices now facing medicine, and the consequences that follow when mission and margin move in opposite directions.

The tradeoffs behind Tim Cook’s success

By almost every measurable business standard, Tim Cook’s tenure as Apple CEO was a historic success. After succeeding Steve Jobs in 2011, he transformed Apple from a beloved consumer tech company into one of the most valuable corporations in history.

In the years that followed, Apple’s market capitalization rose from roughly $350 billion to nearly $4 trillion. Annual profits more than quadrupled. Products like the Apple Watch and AirPods became major revenue drivers, while Apple’s services business fundamentally reshaped the company’s economics.

Through this financial lens, Cook’s leadership received near-universal praise. But those metrics do not capture the personal compromises he made to achieve that level of performance or the price those choices likely carried. Cook’s public persona rested on discipline, restraint and values-based leadership. He framed privacy as a “fundamental human right” and argued that technology should be built around trust, accessibility and respect for users.

But his actions told a different story. And when the values people expound and the actions that they take deviate from one another, psychologists describe the result as cognitive dissonance: an uncomfortable internal conflict.

News articles and podcast retrospectives have questioned Cook’s $1 million donation to Trump’s 2025 inauguration, the custom glass plaque mounted on a 24-karat gold base he gave the president and his attendance at a private White House screening of Melania. There is nothing intrinsically wrong with cultivating a president’s favor, but it is hard to reconcile these actions with Cook’s public image and stated values.

From a financial and shareholder-value perspective, the strategy appears to have worked. As Trump ratcheted up tariffs on imports from India in 2025, the president exempted smartphones and semiconductors, sparing Apple significant costs.

A similar conflict between values and margin appears in Cook’s dealings with China. Over 15 years, he built one of the most sophisticated global supply chains in history, giving Apple a massive competitive advantage. But doing so tied the company to a government known for censorship, human rights violations and a manufacturing system long criticized for its working conditions. To critics, Cook’s willingness to accept those tradeoffs once again ran contrary to his public commitments to privacy, dignity and human-centered technology.

The leaders of publicly traded companies may view such compromises as essential to business success. But what happens when financial optimization pulls clinicians away from their “North Star”?

How financial incentives reshaped medical practice

In 1970, economist Milton Friedman famously argued that the social responsibility of business was to increase profits for shareholders, so long as companies followed the rules of the game. That idea helped define modern American capitalism and the expectations placed on corporate executives.

But medicine is not just another business. Here, the question is what happens to mission-driven doctors when they pursue a finance-first approach, either for their own financial benefit or for the benefit of the hospital, private equity firm or insurer that owns their practice?

Most physicians will never again have the combined autonomy and financial security of previous generations. Industry consolidation has shifted negotiating power away from doctors and toward large hospital systems, insurer-owned medical groups and private equity-backed organizations. These entities have the scale to negotiate higher reimbursement rates, spread administrative costs and operate more efficiently than smaller, independent practices.

Moreover, physician reimbursements from Medicare and Medicaid aren’t keeping pace with inflation. Prior authorization requirements alone force physicians and their staff to spend an average of 13 hours each week navigating approvals, time that could otherwise be spent caring for patients. Furthermore, these financial pressures come on top of the rising cost of staffing, technology, compliance and malpractice coverage.

It is no wonder more than 60% of U.S. physicians are now employed by hospitals, health systems or corporate entities, a dramatic shift from about 40% just a decade ago. Physicians know that joining one of these hospital systems can increase reimbursement rates by 8% to 10% on average, creating a level of financial stability they could not achieve on their own.

Private equity investment has accelerated as well, with roughly 8% of physicians now practicing in PE-backed groups, nearly doubling since 2022. Doctors hope that by selling their practice to private equity, they will receive operational support and long-term financial gain.

In parallel, concierge and direct primary care practices have expanded greatly in recent years. According to Health Affairs, the number of physicians practicing in these models more than doubled between 2018 and 2023, with continued growth since.

What is rarely discussed outside policy circles are the consequences of these financial choices on patient care.

Join a hospital system, and physicians may earn more, but healthcare becomes more unaffordable for both patients and small business owners. Sell a practice to private equity, and studies show the transition is followed by staffing reductions, higher utilization and declines in multiple measures of care quality. Become a concierge doctor, and a physician may earn more caring for 500 patients than previously earned with a panel of 2,000. But that decision also means telling the other 1,500 patients who cannot afford a multi-thousand-dollar annual fee to find another doctor.

The hidden cost of rational decisions

Just as Cook’s financial choices likely caused him cognitive dissonance, physicians who entered medicine with a mission to heal will experience a similar discomfort when their professional choices move them further from their purpose.

Although medical school applications continue to rise, fulfillment among practicing physicians is low. Nearly half of all U.S. physicians report feelings of burnout. Many prefer the term “moral injury” to describe their experience. The phrase, first introduced by psychiatrist Jonathan Shay in the context of war, gained traction in healthcare after physicians Simon Talbot and Wendy Dean argued in 2018 that doctors were not simply burned out, but constrained from delivering the care they knew was right.

However, moral injury implies a lack of agency. It suggests that clinicians are simply victims of forces beyond their control. But it often is applied in ways that obscure the consequences of the choices physicians make when they join a hospital system controlled by a non-clinical administrator, sell to a private equity firm or move into concierge medicine.

This analysis is not a condemnation of those choices. It is an acknowledgment of what has become standard in American medicine and a warning for future generations of physicians. Tim Cook’s story teaches that financial tradeoffs frequently come at personal cost. Legacy is not only about economic results or what others say about us in retrospect. It is built by the choices and decisions we make in real time.

The financial upsides of corporate medicine are clear, but the psychological consequences are rarely discussed. When doctors sell their practices to these entities, part of the quid pro quo is that they will abide by the incentives, constraints and values of the purchasers. And that comes at a steep price.

Caveat emptor: Buyer beware.